Ensem Therapeutics
Ensem Therapeutics is a biotech company in Waltham, United States, founded in 2015. It has raised $77.0M across 2 rounds, most recently a $10.0M Extension Round in October 2023.
Expanding the Universe of Druggable Targets
- Headquarters
- Waltham, Massachusetts
- Employees
- 11–50
- Founded
- 2015
- Business Model
- B2B
- Website
- ensemtx.com
- Total Funding
- $77.0M
- Last Round
- $10.0M Extension RoundOct 2023
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.
About
ENSEM Therapeutics is a preclinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, focused on developing small molecule precision medicines for oncology. The company's proprietary Kinetic Ensemble® platform combines computational AI and deep learning with advanced experimental techniques to identify cryptic binding pockets in traditionally undruggable targets, enabling structure-based drug design against high-value cancer targets. ENSEM's approach captures proteins in motion at ultra-high resolution, uncovering unique therapeutic opportunities that conventional drug discovery methods miss. The company is incubated by CBC Group and serves oncology patients through partnerships with leading research organizations.
Summary
It lists 11–50 employees. It has raised $77.0M in total across 2 rounds, most recently a $10.0M Extension Round in Oct 2023. Investors include GGV Capital, Legend Star and Pavilion Capital.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2023
Sign up to see all 2 events
Funding: Series A through Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ensem-therapeutics"><img src="https://indexed.vc/api/badge/company/ensem-therapeutics" alt="Ensem Therapeutics on Indexed.vc" width="260" height="76" /></a>